Your appetite may start shifting earlier than you expect, meaning food is less appealing, and meals are more satisfying before you've finished them
Patients on warfarin should have more frequent INR monitoring when starting or stopping semaglutide
Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
Men using PT-141 off-label may report different efficacy patterns, though nausea remains a common adverse effect in both groups
Start with 1-2 capsules per day for 3-5 days to assess comfort, then increase to 3 capsules per day
de Boer, H